Evidence map›Paper›PMID 35829971›Full record

Trial reportAIDS and behavior2022

Uptake and Acceptability of MyChoices: Results of a Pilot RCT of a Mobile App Designed to Increase HIV Testing and PrEP Uptake Among Young American MSM.

Katie B Biello, Salvatore R Daddario, Jonathan Hill-Rorie, Donna Futterman, Patrick S Sullivan, Lisa Hightow-Weidman, Jeb Jones, Matthew J Mimiaga, Kenneth H Mayer

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in AIDS and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Katie B BielloDepartment of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, USA. katie_biello@brown.edu.ORCID http://orcid.org/0000-0002-5017-5699
Salvatore R DaddarioThe Fenway Institute, Fenway Health, Boston, MA, USA.
Jonathan Hill-RorieThe Fenway Institute, Fenway Health, Boston, MA, USA.
Donna FuttermanAdolescent AIDS Program, Children's Hospital at Montefiore Medical Center, The Bronx, NY, USA.
Patrick S SullivanDepartment of Epidemiology, Rollins School of Global Public Health, Emory University, Atlanta, GA, USA.
Lisa Hightow-WeidmanDivision of Infectious Diseases, UNC School of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Jeb JonesDepartment of Epidemiology, Rollins School of Global Public Health, Emory University, Atlanta, GA, USA.
Matthew J MimiagaThe Fenway Institute, Fenway Health, Boston, MA, USA.
Kenneth H MayerThe Fenway Institute, Fenway Health, Boston, MA, USA.

Funding

The UNC/Emory Center for Innovative Technology (iTech) across the prevention and care continuumU19HD089881 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HIGHTOW-WEIDMAN, LISA B, SULLIVAN, PATRICK SEAN · 2016 to 2022
$35.8M
Eunice Kennedy Shriver National Institute of Child Health and Human Development U01HD068040National Institute of Allergy and Infectious Diseases P30AI050409
6 · The paper itself

Abstract

Young men who have sex with men (YMSM) remain at disproportionate risk for HIV acquisition in the United States (US), yet use of evidence-based prevention strategies, including routine HIV testing and pre-exposure prophylaxis (PrEP), remain low. Smartphones and mobile app usage are nearly ubiquitous in this population. Given the potential for scalability, a mobile app to increase HIV testing and PrEP use among YMSM has the potential to make an extraordinary public health impact if efficacious. Based on extensive formative, community-engaged research, we developed a theory-driven mobile app-MyChoices-to increase HIV testing and PrEP uptake among YMSM. In a pilot randomized controlled trial (RCT), participants (n = 60) were randomized 2:1 to receive MyChoices or standard of care (SOC). Data from 3 to 6-month post-baseline assessments demonstrate that the app was highly acceptable (System Usability Score; mean = 75.8, SD = 10.7) and feasible (94% used the MyChoices app at least once; mean = 15.3 sessions, SD = 9.8). While not powered to assess efficacy, those in the MyChoices arm had 22% higher prevalence of HIV testing over follow-up compared to those in the SOC arm (NS). There was no difference in PrEP uptake. A fully-powered efficacy trial is warranted; if efficacy is demonstrated, the MyChoices app could be easily scaled to reach YMSM across the US.

Indexed as

HIV InfectionsMobile ApplicationsPre-Exposure ProphylaxisSexual and Gender MinoritiesHIV TestingHomosexuality, MaleHumansMaleUnited StatesHIV testingMen who have sex with menMobile appPrEPYouth

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.